MedTrace Logo

Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds in China

NCT03282357 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 181

Last updated 2021-02-23

Study results available
· View outcomes & findings →

Summary

The objectives of this study are to evaluate the effectiveness and safety of Radiesse for the correction of nasolabial folds (NLFs).

Conditions

  • Correction of the Moderate to Severe Nasolabial Folds

Interventions

DEVICE

Radiesse injectable implant (dermal filler)

Subdermal injection.

DEVICE

Restylane injectable implant (dermal filler)

Subdermal injection

Sponsors & Collaborators

  • Merz North America, Inc.

    lead INDUSTRY

Principal Investigators

  • Merz Medical Expert · Merz North America, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-27
Primary Completion
2018-07-17
Completion
2018-11-30
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03282357 on ClinicalTrials.gov